加利福尼亚亚美尼亚人的癌症发病率
Ani S Movsisyan Vernon1,2, Jeffrey S Hoch1,3, Laura Fejerman1,2
1Department of Public Health Sciences, University of California Davis, Davis, California, USA.
Cancer medicine
|March 16, 2024
概括
这项研究显示,加利福尼亚亚美尼亚人的胃,结肠直肠和甲状腺癌发病率较高. 在亚美尼亚男性中也观察到与烟草有关的癌症的更高率,这凸显了有针对性的研究和干预措施的需要.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 加利福尼亚州拥有美国最大的亚美尼亚人人口.
- 以前的癌症发病率数据可能是不准确的,因为亚美尼亚人在数据库中的错误分类.
- 这是第一个专门研究加利福尼亚亚美尼亚人口癌症发病率的研究.
研究的目的:
- 为了调查加利福尼亚亚美尼亚人癌症发病率模式.
- 为了比较亚美尼亚人的癌症发病率与非西班牙裔白人 (NHWs).
- 为了确定在亚美尼亚人口中潜在的更高发病率的特定癌症类型.
主要方法:
- 利用加利福尼亚癌症登记 (1988-2019) 和亚美尼亚姓名列表来识别病例.
- 计算的比例发病率 (PIR),比较亚美尼亚人和NHWs.
- 使用美国社区调查 (ACS) 人口数据 (2006-2015) 进行了探索性发病率比率 (IRR) 分析.
主要成果:
- 在亚美尼亚人中确定了27,212例癌症诊断.
- 亚美尼亚男性的胃,甲状腺,膀,结肠直肠和肺癌的PIR显著更高.
- 亚美尼亚女性在胃癌,甲状腺癌和结直肠癌中表现出更高的PIR.
- 探索性IRR分析证实男性的胃,膀和结直肠癌的发病率更高,女性的胃癌更高.
结论:
- 在亚美尼亚男性和女性中观察到胃癌,结肠直肠癌和甲状腺癌的发病率较高.
- 在亚美尼亚男性中,与烟草有关的癌症的发病率较高.
- 建议进行进一步的研究,以改善亚美尼亚人口的估计,并调查癌症风险因素.
相关概念视频
02:59Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
01:19Psychoneuroimmunology: Diabetes and Cancer
29
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
29
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:21Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K